L A D Busweiler1,2, B P L Wijnhoven3, M I van Berge Henegouwen4, D Henneman1,2, N C T van Grieken5, M W J M Wouters1,6, R van Hillegersberg7, J W van Sandick6. 1. Dutch Institute for Clinical Auditing, Leiden University Medical Centre, Leiden, The Netherlands. 2. Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands. 3. Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands. 4. Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. 5. Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands. 6. Department of Surgical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 7. Department of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Abstract
BACKGROUND: In 2011, the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group began nationwide registration of all patients undergoing surgery with the intention of resection for oesophageal or gastric cancer. The aim of this study was to describe the initiation and implementation of this process along with an overview of the results. METHODS: The DUCA is part of the Dutch Institute for Clinical Auditing. The audit provides (surgical) teams with reliable, weekly updated, benchmarked information on process and (case mix-adjusted) outcome measures. To accomplish this, a web-based registration was designed, based on a set of predefined quality measures. RESULTS: Between 2011 and 2014, a total of 2786 patients with oesophageal cancer and 1887 with gastric cancer were registered. Case ascertainment approached 100 per cent for patients registered in 2013. The percentage of patients with oesophageal cancer starting treatment within 5 weeks of diagnosis increased significantly over time from 32·5 per cent in 2011 to 41·0 per cent in 2014 (P < 0·001). The percentage of patients with a minimum of 15 examined lymph nodes in the resected specimen also increased significantly for both oesophageal cancer (from 50·3 per cent in 2011 to 73·0 per cent in 2014; P < 0·001) and gastric cancer (from 47·5 per cent in 2011 to 73·6 per cent in 2014; P < 0·001). Postoperative mortality remained stable (around 4·0 per cent) for patients with oesophageal cancer, and decreased for patients with gastric cancer (from 8·0 per cent in 2011 to 4·0 per cent in 2014; P = 0·031). CONCLUSION: Nationwide implementation of the DUCA has been successful. The results indicate a positive trend for various process and outcome measures.
BACKGROUND: In 2011, the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group began nationwide registration of all patients undergoing surgery with the intention of resection for oesophageal or gastric cancer. The aim of this study was to describe the initiation and implementation of this process along with an overview of the results. METHODS: The DUCA is part of the Dutch Institute for Clinical Auditing. The audit provides (surgical) teams with reliable, weekly updated, benchmarked information on process and (case mix-adjusted) outcome measures. To accomplish this, a web-based registration was designed, based on a set of predefined quality measures. RESULTS: Between 2011 and 2014, a total of 2786 patients with oesophageal cancer and 1887 with gastric cancer were registered. Case ascertainment approached 100 per cent for patients registered in 2013. The percentage of patients with oesophageal cancer starting treatment within 5 weeks of diagnosis increased significantly over time from 32·5 per cent in 2011 to 41·0 per cent in 2014 (P < 0·001). The percentage of patients with a minimum of 15 examined lymph nodes in the resected specimen also increased significantly for both oesophageal cancer (from 50·3 per cent in 2011 to 73·0 per cent in 2014; P < 0·001) and gastric cancer (from 47·5 per cent in 2011 to 73·6 per cent in 2014; P < 0·001). Postoperative mortality remained stable (around 4·0 per cent) for patients with oesophageal cancer, and decreased for patients with gastric cancer (from 8·0 per cent in 2011 to 4·0 per cent in 2014; P = 0·031). CONCLUSION: Nationwide implementation of the DUCA has been successful. The results indicate a positive trend for various process and outcome measures.
Authors: Elvira L Vos; Masaya Nakauchi; Mithat Gönen; Jason A Castellanos; Alberto Biondi; Daniel G Coit; Johan L Dikken; Domenico D'Ugo; Henk Hartgrink; Ping Li; Makoto Nishimura; Mark Schattner; Kyo Young Song; Laura H Tang; Ichiro Uyama; Santosha Vardhana; Rob H A Verhoeven; Bas P L Wijnhoven; Vivian E Strong Journal: Ann Surg Date: 2021-12-14 Impact factor: 13.787
Authors: Linlin Yang; Changxian Shen; Cory J Pettit; Tianyun Li; Andrew J Hu; Eric D Miller; Junran Zhang; Steven H Lin; Terence M Williams Journal: Clin Cancer Res Date: 2020-03-27 Impact factor: 12.531
Authors: Naomi Beck; Fieke Hoeijmakers; Erwin M Wiegman; Hans J M Smit; Franz M Schramel; Willem H Steup; Ad F T M Verhagen; Wilhelmina H Schreurs; Michel W J M Wouters Journal: J Thorac Dis Date: 2018-10 Impact factor: 2.895
Authors: Hylke J F Brenkman; Lucas Goense; Lodewijk A Brosens; Nadia Haj Mohammad; Frank P Vleggaar; Jelle P Ruurda; Richard van Hillegersberg Journal: Ann Surg Oncol Date: 2017-02-28 Impact factor: 5.344
Authors: L R van der Werf; J L Dikken; M I van Berge Henegouwen; V E P P Lemmens; G A P Nieuwenhuijzen; B P L Wijnhoven Journal: Ann Surg Oncol Date: 2018-03-09 Impact factor: 5.344
Authors: J A H Gooszen; L Goense; S S Gisbertz; J P Ruurda; R van Hillegersberg; M I van Berge Henegouwen Journal: Br J Surg Date: 2018-02-07 Impact factor: 6.939